Your browser doesn't support javascript.
loading
The safety and tolerability of epacadostat alone and in combination with pembrolizumab in patients with advanced solid tumors: results from a first-in-Japanese phase I study (KEYNOTE-434).
Doi, Toshihiko; Fujiwara, Yutaka; Shitara, Kohei; Shimizu, Toshio; Yonemori, Kan; Matsubara, Nobuaki; Ohno, Izumi; Kogawa, Takahiro; Naito, Yoichi; Leopold, Lance; Munteanu, Mihaela; Yatsuzuka, Naoyoshi; Han, Shi Rong; Samkari, Ayman; Yamamoto, Noboru.
Afiliación
  • Doi T; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan. tdoi@east.ncc.go.jp.
  • Fujiwara Y; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Shitara K; Department of Respiratory Medicine, Mitsui Memorial Hospital, Tokyo, Japan.
  • Shimizu T; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.
  • Yonemori K; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Matsubara N; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Ohno I; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.
  • Kogawa T; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.
  • Naito Y; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.
  • Leopold L; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.
  • Munteanu M; Incyte Corporation, Clinical Development, Wilmington, DE, USA.
  • Yatsuzuka N; Incyte Corporation, Clinical Development, Wilmington, DE, USA.
  • Han SR; MSD K.K. Oncology Science Unit, Tokyo, Japan.
  • Samkari A; MSD K.K. Oncology Science Unit, Tokyo, Japan.
  • Yamamoto N; Department of Clinical Oncology, Merck & Co., Inc., Kenilworth, NJ, USA.
Invest New Drugs ; 39(1): 152-162, 2021 02.
Article en En | MEDLINE | ID: mdl-32564277
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oximas / Sulfonamidas / Anticuerpos Monoclonales Humanizados / Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oximas / Sulfonamidas / Anticuerpos Monoclonales Humanizados / Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Año: 2021 Tipo del documento: Article